Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Greenwich Global Hedge Fund Index up 0.97% (est.) in April (+4.54% YTD)

Monday, May 06, 2013
Opalesque Industry Update - Hedge funds continued to improve through April 2013, adding +0.97% during the month on average, and bringing the Greenwich Global Hedge Fund Index YTD performance up to +4.54%. All primary strategies reported gains for April.

Macro managers are the top performers for April according to initial results, adding an average +2.68% during the month

Event Driven managers added an average +1.91% in April, and are now up 6.10% YTD. This strategy has now surpassed Long-Short Equity as the leading strategy for 2013.

Long-Short Equity struggled the most during April, adding a modest 0.17% on average. Individual results were mixed and highly dispersed, with 58% of managers reporting gains. Many managers may have reduced exposure in anticipation of the annual May 1 sell off and going into the quieter summer trading period.

Greenwich Hedge Fund Index Performance at a Glance

 

Total Return

 

 

 

Apr13

Mar13

YTD

3Mo

1Year

 

 

 

 

 

Greenwich Global Hedge Fund Index

0.97%

0.87%

4.54%

2.06%

6.83%

 

 

 

 

Equity Market Neutral

0.78%

0.45%

3.02%

1.94%

3.94%

 

 

 

 

Event-Driven

1.91%

1.28%

6.10%

3.42%

11.28%

 

 

 

 

Arbitrage

1.04%

1.15%

4.20%

2.84%

9.45%

 

 

 

 

Long/Short Equity

0.17%

1.04%

5.37%

1.78%

7.58%

 

 

 

 

Futures

1.81%

0.52%

2.54%

1.39%

0.20%

 

 

 

 

Macro

2.68%

0.72%

5.36%

3.42%

7.87%

 

 

 

 

Long/Short Credit

1.42%

0.42%

3.58%

2.06%

11.14%

 

 

 

 

Multi-Strategy

1.08%

0.71%

3.94%

2.09%

6.25%

 

 

 

 

 

Barclays Aggregate Bond Index

1.01%

0.08%

0.89%

1.60%

3.68%

 

 

 

 

S&P 500

1.93%

3.75%

12.74%

7.18%

16.89%

 

 

 

 

MSCI World Equity Index

2.90%

2.09%

10.28%

5.03%

14.08%

 

 

 

 

FTSE 100

0.29%

0.80%

9.03%

2.44%

12.07%

 

 

 

 

* The table contains initial estimates. Firm estimates for all indices will be published mid-month. The GGHFI current month return will be finalized on the third business day of June.

Greenwich Alternative Investments, LLC (and its affiliates) manages one of the world’s largest hedge fund databases and is among the oldest providers of hedge fund indices, asset management services, and research to institutional investors worldwide. www.greenwichai.com

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its